학술논문 – 법학도서관

학술논문

replay검색결과 돌아가기

search검색화면

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

Document Type

Article

Author

Giugliano, R.P.; Park, J.-G.; Kanevsky, E.; Sabatine, M.S.; Pedersen, T.R.; De Ferrari, G.M.; Gaciong, Z.A.; Ceska, R.; Toth, K.; Gouni-Berthold, I.; Lopez-Miranda, J.; Schiele, F.; Mach, F.; Ott, B.R.; Pineda, A.L.; Somaratne, R.; Wasserman, S.M.; Keech, A.C.; Sever, P.S.

Source

In: The Lancet. (The Lancet, 28 October - 3 November 2017, 390(10106):1962-1971)

Subject

Language

English

ISSN

1474547X
01406736

Online Access

Full Text (ScienceDirect 종량제) Full Text (ScienceDirect) Full Text (Clinical Key) Full Text (ProQuest Central) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일